Natural history of non-lethal Raine syndrome during childhood.
Children
Osteosclerosis
Raine syndrome
Rickets
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
16 04 2020
16 04 2020
Historique:
received:
24
10
2019
accepted:
31
03
2020
entrez:
18
4
2020
pubmed:
18
4
2020
medline:
22
6
2021
Statut:
epublish
Résumé
Raine syndrome (RS) is a rare autosomal recessive disorder caused by biallelic loss-of-function mutations of FAM20C. The most common clinical features are microcephaly, exophthalmos, hypoplastic nose and severe midface hypoplasia, leading to choanal atresia. The radiological findings include generalized osteosclerosis and brain calcifications. RS is usually lethal during the neonatal period due to severe respiratory distress. However, there exists a non-lethal RS form, the phenotype of which is extremely heterogeneous. There is paucity of data about clinical course and life expectancy of these patients. This is the first description of follow-up features of non-lethal RS patients. Moreover, we present three unpublished cases. There are five Asian and two Arab patients. All were born to consanguineous parents. The most common neonatal comorbidity was respiratory distress secondary to choanal atresia. A variable degree of neurodevelopmental delay was seen in the majority of our cases and seizures and hearing or vision involvement were also frequent. Neurological and orthopedic issues were the most frequent complications seen at follow-up in our group. Persistent hypophosphatemic rickets was the most striking endocrinological manifestation, which was scarcely responsive to therapy with phosphate salts and alfacalcidol. Life expectancy of our patients goes beyond childhood, with the oldest of those described being 18 years old at present. Manifestations of RS in those surviving the neonatal period are being increasingly recognized. Our study supports previous findings and provides clinical and biochemical observations and data from longer follow up. Finally, we propose multidisciplinary follow up for patients with non-lethal RS.
Sections du résumé
BACKGROUND
Raine syndrome (RS) is a rare autosomal recessive disorder caused by biallelic loss-of-function mutations of FAM20C. The most common clinical features are microcephaly, exophthalmos, hypoplastic nose and severe midface hypoplasia, leading to choanal atresia. The radiological findings include generalized osteosclerosis and brain calcifications. RS is usually lethal during the neonatal period due to severe respiratory distress. However, there exists a non-lethal RS form, the phenotype of which is extremely heterogeneous. There is paucity of data about clinical course and life expectancy of these patients.
RESULTS
This is the first description of follow-up features of non-lethal RS patients. Moreover, we present three unpublished cases. There are five Asian and two Arab patients. All were born to consanguineous parents. The most common neonatal comorbidity was respiratory distress secondary to choanal atresia. A variable degree of neurodevelopmental delay was seen in the majority of our cases and seizures and hearing or vision involvement were also frequent. Neurological and orthopedic issues were the most frequent complications seen at follow-up in our group. Persistent hypophosphatemic rickets was the most striking endocrinological manifestation, which was scarcely responsive to therapy with phosphate salts and alfacalcidol. Life expectancy of our patients goes beyond childhood, with the oldest of those described being 18 years old at present.
CONCLUSIONS
Manifestations of RS in those surviving the neonatal period are being increasingly recognized. Our study supports previous findings and provides clinical and biochemical observations and data from longer follow up. Finally, we propose multidisciplinary follow up for patients with non-lethal RS.
Identifiants
pubmed: 32299476
doi: 10.1186/s13023-020-01373-0
pii: 10.1186/s13023-020-01373-0
pmc: PMC7164176
doi:
Substances chimiques
Extracellular Matrix Proteins
0
Casein Kinase I
EC 2.7.11.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
93Références
Am J Med Genet. 1992 Jul 15;43(5):860-4
pubmed: 1642277
PLoS One. 2012;7(8):e42988
pubmed: 22900076
Osteoporos Int. 2019 Mar;30(3):685-689
pubmed: 30151622
Eur J Med Genet. 2016 Nov;59(11):577-583
pubmed: 27667191
Bone. 2014 Oct;67:56-62
pubmed: 24982027
Am J Hum Genet. 2007 Nov;81(5):906-12
pubmed: 17924334
Calcif Tissue Int. 2019 Nov;105(5):567-572
pubmed: 31471673
Skeletal Radiol. 1991;20(2):117-9
pubmed: 2020859
Clin Dysmorphol. 2001 Jul;10(3):227-9
pubmed: 11446420
Bone. 2014 Oct;67:145-51
pubmed: 25026495
Am J Med Genet A. 2018 Mar;176(3):682-686
pubmed: 29341424
J Bone Miner Res. 2017 Apr;32(4):757-769
pubmed: 27862258
BMC Med Genet. 2018 May 11;19(1):76
pubmed: 29751744
Am J Med Genet A. 2019 Sep;179(9):1866-1871
pubmed: 31297960
BMC Med Genet. 2015 Feb 21;16:8
pubmed: 25928877
Clin Genet. 2011 Aug;80(2):177-83
pubmed: 20825432
Clin Dysmorphol. 2003 Apr;12(2):89-93
pubmed: 12868469
J Med Genet. 1989 Dec;26(12):786-8
pubmed: 2614802
Clin Dysmorphol. 2010 Jul;19(3):153-6
pubmed: 20453638
Clin Dysmorphol. 2003 Jul;12(3):153-60
pubmed: 14564151
Eur J Med Genet. 2014 Sep;57(9):536-42
pubmed: 25019372
J Bone Miner Res. 2011 Jul;26(7):1381-8
pubmed: 21538511